Tumor heterogeneity plays a key role in prostate cancer prognosis, therapy selection,
relapse, and acquisition of treatment resistance. Prostate cancer presents a heterogeneous …

Management of patients with prostate cancer (PCa) is often challenging due to the
difference in the biology of cancer between patients and the various genetic alterations …

Pancreatic progenitor cell differentiation and proliferation factor (PPDPF) has been reported
to play a role in tumorigenesis. However, its function in hepatocellular carcinoma (HCC) …

Discovering disease biomarkers from gene expression data has been greatly advanced by
feature selection (FS) methods, especially using ensemble FS (EFS) strategies with …

Featured Application This paper presents a prediction method for the biochemical
recurrence of prostate cancer following radical prostatectomy using partial correlation and a …

Resistance to radiotherapy is frequently observed in the clinic and leads to poor prognosis
of non-small cell lung cancer (NSCLC). How to overcome resistance to radiotherapy is a …

Feature selection in clustering is a hard task which involves simultaneously the discovery of
relevant clusters as well as relevant variables with respect to these clusters. While feature …

Prostate cancer (PC) is one of the most common cancers in men and becoming the second
leading cause of cancer fatalities. At present, the lack of effective strategies for prognosis of …

There is a problem of clinical trial failure, as each new drug should surpass the effectiveness
of existing treatment regimens, which becomes increasingly challenging over time. Another …

Feature selection in clustering is a hard task which involves simultaneously the discovery of
relevant clusters as well as relevant variables with respect to these clusters. While feature …